| http://www.w3.org/ns/prov#value | - "Currently, most drugs are developed using a screening technique where you try a lot of candidate compounds against targets to 'see what sticks'," says Armentrout. "Instead, we are designing very specific drugs based on their molecular structure, with target molecules that bind to receptors on specific types of cancer cells.
|
